0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP SC684475 2023-04-01 2024-03-31 SC684475 2024-03-31 SC684475 2023-03-31 SC684475 2022-04-01 2023-03-31 SC684475 2023-03-31 SC684475 2022-03-31 SC684475 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 SC684475 bus:Director1 2023-04-01 2024-03-31 SC684475 core:ShareCapital 2024-03-31 SC684475 core:ShareCapital 2023-03-31 SC684475 bus:SmallEntities 2023-04-01 2024-03-31 SC684475 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 SC684475 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 SC684475 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 SC684475 bus:FullAccounts 2023-04-01 2024-03-31 SC684475 bus:OrdinaryShareClass1 2024-03-31 SC684475 bus:OrdinaryShareClass1 2023-03-31
COMPANY REGISTRATION NUMBER: SC684475
B & PD GP Limited
Filleted Unaudited Financial Statements
For the year ended
31 March 2024
B & PD GP Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
Current assets
Cash at bank and in hand
6
6
----
----
Net current assets
6
6
----
----
Total assets less current liabilities
6
6
----
----
Capital and reserves
Called up share capital
4
6
6
----
----
Shareholders funds
6
6
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 19 November 2024 , and are signed on behalf of the board by:
E M Scott
Director
Company registration number: SC684475
B & PD GP Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 61 Dublin Street, Edinburgh, EH3 6NL.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Financial instruments
A financial asset or financial liability is recognised only when the company becomes a party to the contractual provisions of the financial instrument. Basic financial assets, which include trade and other receivables and cash and bank balances, are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future receipts discounted at the market rate of interest for a similar debt instrument. Basic financial liabilities, which include trade creditors and other payables, are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future receipts discounted at the market rate of interest for a similar debt instrument. At each reporting date the company assesses whether there is objective evidence that any financial asset has been impaired. A provision for impairment is established when there is objective evidence that the company will not be able to collect all amounts due. The amount of the provision is recognised immediately in profit or loss.
4. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 0.01 each
600
6
600
6
----
----
----
----